Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Small Pharma

Ayahuasca psychedelic DMT shows promise as depression therapy

Study finds participants saw reduction in depressive symptoms as researchers welcome ‘promising’ results

The Guardian - US

Psychedelic drug trip improves symptoms of depression for six months, breakthrough study finds

Dimethyltryptamine is a powerful hallucinogenic found in several plants and can be smoked, snorted or mixed with ayahuasca

The Independent UK

Psychedelic drug improves symptoms of depression for six months – study

Dimethyltryptamine is a powerful hallucinogenic found in several plants and can be smoked, snorted or mixed with ayahuasca.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Psychedelic drugs can help tackle depression, study suggests

The psychedelic drug has been more effective for treating depression than other substances including LSD

The Independent UK

This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out

Small Pharma Inc.

Benzinga

Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway

Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31, 2022. For the period numbers show:

Benzinga

Small Pharma Obtains U.S. Patent For Injectable DMT, First In Company's Psychedelic Portfolio

Biotech psychedelics company Small Pharma Inc.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know

Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras.

Benzinga

DMT Therapy Developer Small Pharma Posts Financial Results, Reaffirms Potential Of Short-Acting Psychedelics

Biotech company Small Pharma Inc. (OTCQB: DMTTF), producer of short-acting psychedelic-assisted therapies for diverse mental health conditions, announced its financial results earlier this month for the fiscal year ended Feb. 28, 2022.

Benzinga

A Deeper Look At DMT Trials & Studies

This article by Elisabetta Fato was originally published on Microdose and appears here with permission.

Benzinga

Cybin, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68

Benzinga

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Benzinga

Psychedelic Stock Gainers And Losers From April 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Psychedelic Stock Gainers And Losers From April 11, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17

Benzinga

Is The UK Becoming A Global Center For Psychedelic Medicine?

This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research isn’t enough to convince you, then two more crucial factors surely will. Firstly, a new ‘accelerated pathway’ has…

Benzinga

Top 5 Most Influential Psychedelic Studies

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming mainstream medicines. When it…

Benzinga

Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 11.18% at $1.03

Benzinga

Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Wellbeing Digital (OTC:KONEF) shares closed up 148.45% at $0.40 LOSERS:

Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23

Benzinga

Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20

Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49

Benzinga

Psychedelic Stock Gainers And Losers From January 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 14.55% at $0.21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

Psychedelic Spotlight

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.